Press Release-04-104, Advisory Committee on the Medical Uses Isotopes to Meet October 13 - 14 in Rockville, Maryland: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
 
(Created page by program invented by StriderTol)
 
Line 19: Line 19:


=Text=
=Text=
{{#Wiki_filter:NRC NEWS             U.S. NUCLEAR REGULATORY COMMISSION Office of Public Affairs             Telephone: 301/415-8200 Washington, DC 20555-0001       E-mail: opa@nrc.gov Web Site: http://www.nrc.gov/OPANo. 04-104                                                                                                                     September 1, 2004ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES TO MEETOCTOBER 13 - 14 IN ROCKVILLE, MARYLANDThe Advisory Committee on the Medical Uses of Isotopes (ACMUI) will meet at the NuclearRegulatory Commission's headquarters in Rockville, Md., on Oct. 13-14.The meeting's public session will run from 10 a.m. to 5 p.m. Oct. 13 and from 8 a.m. to 5 p.m.
{{#Wiki_filter:NRC NEWS U.S. NUCLEAR REGULATORY COMMISSION Office of Public Affairs       Telephone: 301/415-8200 Washington, DC 20555-0001       E-mail: opa@nrc.gov Web Site: http://www.nrc.gov/OPA No. 04-104                                                                           September 1, 2004 ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES TO MEET OCTOBER 13 - 14 IN ROCKVILLE, MARYLAND The Advisory Committee on the Medical Uses of Isotopes (ACMUI) will meet at the Nuclear Regulatory Commissions headquarters in Rockville, Md., on Oct. 13-14.
Oct. 14.Agenda items for discussion in the public sessions include the use of Iodine-125 brachytherapyseeds as markers; proposed changes to abnormal occurrence criteria; discussion of medical event criteria; and an update on the St. Joseph's Mercy Hospital dose reconstruction case. A complete agenda will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/schedules/2004/ . Questions from the public will be permitted during the open sessions, at the discretion of the committee chairman. Persons who wish to provide a written statement should submit a reproducible copy to Angela R. McIntosh, Office of Nuclear Materials Safety and Safeguards, U.S. Nuclear Regulatory Commission, Mail Stop T-8F5, Washington, DC 20555-0001. Statements may also be e-mailed to Ms. McIntosh at arm@nrc.gov . Submissions should be postmarked by Sept. 15 and mustpertain to the topics on the meeting agenda. For further information, contact Ms. McIntosh at (301)
The meetings public session will run from 10 a.m. to 5 p.m. Oct. 13 and from 8 a.m. to 5 p.m.
 
Oct. 14.
415-5030.Transcripts of the meeting and written comments will be available about Jan. 14, 2005, on the NRC's web site, http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/ , and in the NRC Public Document Room, 11555 Rockville Pike, telephone (800) 397-4209 or (301) 415-4737.  
Agenda items for discussion in the public sessions include the use of Iodine-125 brachytherapy seeds as markers; proposed changes to abnormal occurrence criteria; discussion of medical event criteria; and an update on the St. Josephs Mercy Hospital dose reconstruction case. A complete agenda will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/schedules/2004/ .
###}}
Questions from the public will be permitted during the open sessions, at the discretion of the committee chairman. Persons who wish to provide a written statement should submit a reproducible copy to Angela R. McIntosh, Office of Nuclear Materials Safety and Safeguards, U.S. Nuclear Regulatory Commission, Mail Stop T-8F5, Washington, DC 20555-0001. Statements may also be e-mailed to Ms. McIntosh at arm@nrc.gov . Submissions should be postmarked by Sept. 15 and must pertain to the topics on the meeting agenda. For further information, contact Ms. McIntosh at (301) 415-5030.
Transcripts of the meeting and written comments will be available about Jan. 14, 2005, on the NRCs web site, http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/ , and in the NRC Public Document Room, 11555 Rockville Pike, telephone (800) 397-4209 or (301) 415-4737.
                                                      ###}}

Latest revision as of 01:56, 24 November 2019

Press Release-04-104: Advisory Committee on the Medical Uses Isotopes to Meet October 13 - 14 in Rockville, Maryland
ML042450556
Person / Time
Issue date: 09/01/2004
From:
Office of Public Affairs
To:
References
Press Release-04-104
Download: ML042450556 (1)
v • d • e


Text

NRC NEWS U.S. NUCLEAR REGULATORY COMMISSION Office of Public Affairs Telephone: 301/415-8200 Washington, DC 20555-0001 E-mail: opa@nrc.gov Web Site: http://www.nrc.gov/OPA No.04-104 September 1, 2004 ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES TO MEET OCTOBER 13 - 14 IN ROCKVILLE, MARYLAND The Advisory Committee on the Medical Uses of Isotopes (ACMUI) will meet at the Nuclear Regulatory Commissions headquarters in Rockville, Md., on Oct. 13-14.

The meetings public session will run from 10 a.m. to 5 p.m. Oct. 13 and from 8 a.m. to 5 p.m.

Oct. 14.

Agenda items for discussion in the public sessions include the use of Iodine-125 brachytherapy seeds as markers; proposed changes to abnormal occurrence criteria; discussion of medical event criteria; and an update on the St. Josephs Mercy Hospital dose reconstruction case. A complete agenda will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/schedules/2004/ .

Questions from the public will be permitted during the open sessions, at the discretion of the committee chairman. Persons who wish to provide a written statement should submit a reproducible copy to Angela R. McIntosh, Office of Nuclear Materials Safety and Safeguards, U.S. Nuclear Regulatory Commission, Mail Stop T-8F5, Washington, DC 20555-0001. Statements may also be e-mailed to Ms. McIntosh at arm@nrc.gov . Submissions should be postmarked by Sept. 15 and must pertain to the topics on the meeting agenda. For further information, contact Ms. McIntosh at (301) 415-5030.

Transcripts of the meeting and written comments will be available about Jan. 14, 2005, on the NRCs web site, http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/ , and in the NRC Public Document Room, 11555 Rockville Pike, telephone (800) 397-4209 or (301) 415-4737.

Retrieved from "https://kanterella.com/w/index.php?title=Press_Release-04-104,_Advisory_Committee_on_the_Medical_Uses_Isotopes_to_Meet_October_13_-_14_in_Rockville,_Maryland&oldid=2199098"